Sunflower: Subsidiary company Betar Pharmaceutical obtained the registration certificate for rosuvastatin capsules.

Sunflower announcement: Beide Pharmaceutical, a subsidiary, recently received the "Drug Registration Certificate" of Rosuvastatin Capsules issued by the National Medical Products Administration. Rosuvastatin Capsules are used for anemia caused by chronic kidney disease, including dialysis and non-dialysis patients. This original drug was approved for listing in China in 2018. Beide Pharmaceutical received the acceptance notification on February 8, 2025, and was approved by the drug regulatory authority recently. According to relevant national policies, obtaining the "Drug Registration Certificate" this time is equivalent to passing consistency evaluation. This variety has been included in the national medical insurance catalog B and is a variety in the 2025 national medical insurance catalog.